Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120

J Virol. 1992 Dec;66(12):7543-8. doi: 10.1128/JVI.66.12.7543-7548.1992.

Abstract

Levels of human immunodeficiency virus (HIV) DNA, RNA, or p24 antigen and reverse transcriptase activity in T-cell cultures treated with 500 IU of recombinant alpha interferon (rIFN alpha) per ml were comparable to those in control cultures. Radioimmunoprecipitation analysis of proteins in lysates of IFN-treated T cells documented a marked accumulation of HIV proteins. Localization of gp120 by immunofluorescence showed a diffuse pattern in IFN-treated cells quite distinct from the ring pattern in untreated control cells. That large quantities of gp120 in aberrant cell compartments might affect HIV morphogenesis was confirmed in infectivity studies: virions from IFN-treated cells were 100- to 1,000-fold less infectious than an equal number of virions from control cells. Direct examination of IFN-treated and control HIV-infected cells by transmission electron microscopy showed little difference in the number or distribution of viral particles. However, quantitation of gp120 by immunogold particle analysis revealed a marked depletion of envelope glycoprotein in virions released from IFN-treated cells. This defect in gp120 assembly onto mature viral particles provides a molecular basis for this loss of infectivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • DNA, Viral / analysis
  • DNA, Viral / metabolism
  • HIV Core Protein p24 / analysis
  • HIV Core Protein p24 / metabolism
  • HIV Envelope Protein gp120 / genetics
  • HIV Envelope Protein gp120 / metabolism*
  • HIV Reverse Transcriptase
  • HIV-1 / drug effects*
  • HIV-1 / pathogenicity
  • HIV-1 / physiology*
  • Humans
  • Interferon Type I / pharmacology*
  • RNA, Viral / analysis
  • RNA, Viral / metabolism
  • RNA-Directed DNA Polymerase / metabolism
  • Recombinant Proteins
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / microbiology
  • Viral Proteins / isolation & purification
  • Viral Proteins / metabolism*
  • Virion / drug effects
  • Virion / pathogenicity
  • Virion / physiology*

Substances

  • DNA, Viral
  • HIV Core Protein p24
  • HIV Envelope Protein gp120
  • Interferon Type I
  • RNA, Viral
  • Recombinant Proteins
  • Viral Proteins
  • HIV Reverse Transcriptase
  • RNA-Directed DNA Polymerase